Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypofractionated Dose”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Testing effectiveness (Phase 2)UnknownNCT04543890
What this trial is testing

A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC

Who this might be right for
Small Cell Lung Cancer Limited Stage
Zhejiang Cancer Hospital 300
Not applicableUnknownNCT02446366
What this trial is testing

Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate Adenocarcinoma
University of Southern California 24
Testing effectiveness (Phase 2)Looking for participantsNCT06389422
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyPembrolizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableEnded earlyNCT03402737
What this trial is testing

SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N

Who this might be right for
Head and Neck Neoplasm
University Hospital, Ghent 6
Not applicableNot Yet RecruitingNCT07210502
What this trial is testing

Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Royal Surrey County Hospital NHS Foundation Trust 220
Early research (Phase 1)Active Not RecruitingNCT04046575
What this trial is testing

Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer

Who this might be right for
Esophagus CancerEsophageal CancerCancer of the Esophagus
Washington University School of Medicine 12
Early research (Phase 1)Study completedNCT00822887
What this trial is testing

Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas

Who this might be right for
Malignant Gliomas
University of Colorado, Denver 13
Early research (Phase 1)Study completedNCT04951063
What this trial is testing

Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC

Who this might be right for
Locally Advanced Lung Carcinoma
Sun Yat-sen University 18
Testing effectiveness (Phase 2)UnknownNCT06233981
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyTislelizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)UnknownNCT03651375
What this trial is testing

Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall

Who this might be right for
SarcomaFibrosarcomaLeiomyosarcoma+14 more
Maria Sklodowska-Curie National Research Institute of Oncology 46
Not applicableStudy completedNCT03082846
What this trial is testing

Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial

Who this might be right for
GliomaRadiotherapy, Intensity-ModulatedMaximum Tolerated Dose
Xue Xiaoying 16
Large-scale testing (Phase 3)Active Not RecruitingNCT01444820
What this trial is testing

Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital 329
Testing effectiveness (Phase 2)Study completedNCT00214097
What this trial is testing

Phase I/II Hypofractionated Radiotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 347
Testing effectiveness (Phase 2)Looking for participantsNCT06461819
What this trial is testing

Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)

Who this might be right for
Low-to-intermediate-risk Prostate Carcinoma
Samsung Medical Center 33
Not applicableLooking for participantsNCT06995664
What this trial is testing

Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Management

Who this might be right for
Renal Cell CarcinomaRenal Cell Carcinoma Metastatic
Royal Marsden NHS Foundation Trust 24
Testing effectiveness (Phase 2)Study completedNCT00714753
What this trial is testing

Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 5
Testing effectiveness (Phase 2)UnknownNCT02367443
What this trial is testing

Hypofractionated Accelerated Radiotherapy With Concomitant Chemotherapy for NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Independent Public Care Health Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Centre 92
Early research (Phase 1)Study completedNCT01219790
What this trial is testing

ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma

Who this might be right for
Prostate Adenocarcinoma
Institut Cancerologie de l'Ouest 30
Testing effectiveness (Phase 2)UnknownNCT00938418
What this trial is testing

Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage III Non-Small Cell Lung Cancer
National University Hospital, Singapore 43
Load More Results